T. Rowe Price Associates’s Rapid Micro Biosystems RPID Stock Holding History

T. Rowe Price Associates’s Portfolio RPID Stock Details RPID Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-760,438	Closed	-$997K	–	2936
2023 Q1	$997K	Sell	760,438 -40,066	-5%	-$52K	﹤0.01%	1791
2022 Q4	$905K	Sell	800,504 -37,351	-4%	-$90.4K	﹤0.01%	1820
2022 Q3	$2.71M	Sell	837,855 -2,589,299	-76%	-$10M	﹤0.01%	1339
2022 Q2	$14.7M	Sell	3,427,154 -20,032	-0.6%	-$93.2K	﹤0.01%	1243
2022 Q1	$23.4M	Buy	3,447,186 +1,247,440	+57%	+$9.19M	﹤0.01%	1194
2021 Q4	$23.2M	Buy	2,199,746 +343,704	+19%	+$5.37M	﹤0.01%	1250
2021 Q3	$33.9M	Buy	+1,856,042	New	+$38.3M	﹤0.01%	1149

Other funds holding RPID

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

KLM

Kennedy Lewis Management New York $21.9M AUM 12.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

GCM

Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

AWGLSCP

ABG-WTT Global Life Science Capital Partners Central, Hong Kong, Hong Kong $8.55M AUM 12.76% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Advent International Boston, Massachusetts $17.7B AUM 5.23% 1-Year Est. Return

T. Rowe Price Associates's RPID Position: Q2 2023 in Review

T. Rowe Price Associates sold out of Rapid Micro Biosystems (RPID) in Q2 2023, closing a stake of 760,438 shares — an estimated $997K sold.

T. Rowe Price Associates first reported a position in RPID in Q3 2021 and held it in 7 quarters. The position peaked at $33.9M in Q3 2021. 24 funds tracked by Wall St. Rank hold RPID as of Q2 2023.

T. Rowe Price Associates reported no remaining Rapid Micro Biosystems position as of Q2 2023 after selling out during the quarter.
T. Rowe Price Associates sold 760,438 Rapid Micro Biosystems shares in Q2 2023, an estimated $997K.
T. Rowe Price Associates first reported a position in Rapid Micro Biosystems in Q3 2021 and held it in 7 quarters.
T. Rowe Price Associates's Rapid Micro Biosystems position peaked at $33.9M in Q3 2021.
24 funds tracked by Wall St. Rank held Rapid Micro Biosystems as of Q2 2023.

Based on T. Rowe Price Associates's 13F filing for Q2 2023, filed 14 Aug 2023.